Baseline white blood cell count-to-apolipoprotein A1 ratio as a novel predictor of long-term adverse outcomes in patients who underwent percutaneous coronary intervention: a retrospective cohort study

Table 2 Outcomes comparison between each group

Variables	WAR< 5.25	5.25 ≤ WAR≤7.15	WAR ≥7.15	HR (95%CI)^a	P value	Adjusted HR (95%CI)^{a, b}	P value
Variables	(n = 1889)	(n = 1892)	(n = 1897)	HR (95%CI)^a	P value	Adjusted HR (95%CI)^{a, b}	P value
ACM, n (%)	85 (4.5)	90 (4.8)	118 (6.2)	1.484 (1.123–1.962)	0.007	1.626 (1.214–2.179)	0.001
CM, n (%)	72 (3.8)	72 (3.8)	91 (4.8)	1.347 (0.989–1.835)	0.059	1.455 (1.051–2.014)	0.024
MACCE, n (%)	240 (12.7)	287 (15.2)	281 (14.8)	1.261 (1.062–1.499)	0.008	1.212 (1.011–1.454)	0.038
MACE, n (%)	221 (11.7)	256 (13.5)	260 (13.7)	1.267 (1.059–1.516)	0.010	1.238 (1.025–1.495)	0.027

Note: ACM All-cause mortality, CM Cardiac mortality, MACCE Major adverse cardiovascular and cerebrovascular events, MACE Major adverse cardiovascular events. ^aHR for comparison of WAR ≥7.15 group with WAR< 5.25 group. ^badjustments of age, sex, smoking, drinking, DBP, Cr, UA, GLU, TC, HDL-C and LDL-C

ISSN: 1476-511X